May 25th, 2010
Innoventus closes deal regarding new innovative system for urine catheters
Dec 8th, 2009
Innoventus Project AB tecknar avtal med amerikanskt bioteknikföretag.
Nov 24th, 2009
Innoventus Project AB appoints Malin Graffner Nordberg as CEO
Dec 9th, 2008
Fluoroscerande proteiner handlar inte bara om årets Nobelpris i kemi utan är även ett område för framgångsrik forskning i Uppsala. Läs pressmeddelande.
Jan 22nd, 2008
Innoventus Project AB’s periodontitis project enters Phase I. Read press release
Conferences:
Europerio6, Stockholm, June 4-6, 2009
31st Annual San Antonio Breast Cancer Symposium, Dec 10-14
MEDICA 2008, Düsseldorf, Nov 19-22
CIRSE 2008, Copenhagen, Sep 13-17
SIR 2008, Washington, March 15-20
Bio-Europe Spring 2008, Madrid, April

life science and biotech projects
We work in the phase where technology ventures are too immature to meet traditional investment criteria.
Our mission is to develop novel technology concepts and transform them into objects of visible and measurable commercial value.
Our exit strategy is to attract industrial and venture capital.
Our unique approach of 'hands-on' management plus the necessary capital resources ensures cost-effective and speedy critical early-stage development.
Review our success factors to see what we can offer you.
For more information, please contact us.

Innoventus follows a well-planned and proven strategy for transforming bioscience innovations into successful product launches.

